Go Deep
Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,158 | -0.9 | 1.20 | 0.01 | 320.14 |
| Oct 2026 | 23,167 | -0.9 | 1.19 | 0.01 | 317.30 |
| Oct 2026 | 21,384 | -0.8 | 1.17 | 0.01 | 311.95 |
| Oct 2026 | 21,387 | -0.8 | 1.16 | 0.01 | 311.00 |
| Oct 2026 | 21,428 | -0.8 | 1.11 | 0.01 | 297.22 |
| Oct 2026 | 21,414 | -0.8 | 1.13 | 0.01 | 301.11 |
Intensity Therapeutics, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -3,007,000.0 | -2,434,000.0 | -3,051,000.0 | -2,671,000.0 |
| EPS | -1.1 | -1.0 | — | -1.5 |
Intensity Therapeutics, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -11,606,000.0 | -16,268,000.0 | -10,538,000.0 | -7,582,000.0 | — |
| EPS | -8.6 | -29.2 | -34.5 | -54.7 | — |
Intensity Therapeutics, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 14,101,000.0 | 4,783,000.0 | 17,295,000.0 | 1,757,000.0 | — |
| Total Liabilities | 2,225,000.0 | 1,865,000.0 | 4,133,000.0 | 16,855,000.0 | — |
| Total Equity | 11,876,000.0 | 2,918,000.0 | 13,162,000.0 | -15,098,000.0 | — |
Owes vs Owns
Intensity Therapeutics, Inc. owed $0.20 for every $1 it owned in Jun 2026, down from $9.59 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.20× | 0.16× | 0.39× | 0.24× | 9.59× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Intensity Therapeutics, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 84.5%Fixed assets (tangible) 0.7%Other assets 14.8%
How it's funded — Dec 2025
Long-term debt 0.6%Payables 4.1%Other liabilities 10.9%Shareholders' equity 84.2%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 11.9 | 2.6 | 14.8 | 1.3 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.1 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.1 | 0.1 | 0.1 | 0.1 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 2.1 | 2.1 | 2.4 | 0.2 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 4.3 |
| Long-term debt | 0.1 | 0.1 | 0.1 | 0.0 |
| Payables | 0.6 | 1.2 | 3.0 | 0.6 |
| Other liabilities | 1.5 | 0.5 | 0.9 | 11.9 |
| Shareholders' equity | 11.9 | 2.9 | 13.2 | -15.1 |
| Net tangible assets | 11.9 | 2.9 | 13.2 | -15.1 |
Intensity Therapeutics, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -9,233,000.0 | -15,220,000.0 | -7,205,000.0 | -5,477,000.0 | — |
| Investing Activities | 0.0 | 6,354,000.0 | -6,023,000.0 | 0.0 | — |
| Financing Activities | 18,564,000.0 | 2,900,000.0 | 20,472,000.0 | 2,250,000.0 | — |